BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34642245)

  • 1. Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice.
    Zhang C; Lei L; Yang X; Ma K; Zheng H; Su Y; Jiao A; Wang X; Liu H; Zou Y; Shi L; Zhou X; Sun C; Hou Y; Xiao Z; Zhang L; Zhang B
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34642245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer.
    Kim M; Min YK; Jang J; Park H; Lee S; Lee CH
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34253638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
    Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing.
    Zheng C; Zheng L; Yoo JK; Guo H; Zhang Y; Guo X; Kang B; Hu R; Huang JY; Zhang Q; Liu Z; Dong M; Hu X; Ouyang W; Peng J; Zhang Z
    Cell; 2017 Jun; 169(7):1342-1356.e16. PubMed ID: 28622514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial immunotherapy induces tumor-infiltrating CD8
    Van Braeckel-Budimir N; Dolina JS; Wei J; Wang X; Chen SH; Santiago P; Tu G; Micci L; Al-Khami AA; Pfister S; Ram S; Sundar P; Thomas G; Long H; Yang W; Potluri S; Salek-Ardakani S
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.
    Isoyama S; Mori S; Sugiyama D; Kojima Y; Tada Y; Shitara K; Hinohara K; Dan S; Nishikawa H
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinvigorating exhausted CD8
    Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
    Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptomics reveals a low CD8
    Peng YL; Xiong LB; Zhou ZH; Ning K; Li Z; Wu ZS; Deng MH; Wei WS; Wang N; Zou XP; He ZS; Huang JW; Luo JH; Liu JY; Jia N; Cao Y; Han H; Guo SJ; Dong P; Yu CP; Zhou FJ; Zhang ZL
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35121646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile.
    Ueyama A; Nogami W; Nashiki K; Haruna M; Miwa H; Hagiwara M; Nagira M; Wada H; Nagira Y
    J Immunol; 2023 Aug; 211(4):673-682. PubMed ID: 37350632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.
    Adorno Febles VR; Hao Y; Ahsan A; Wu J; Qian Y; Zhong H; Loeb S; Makarov DV; Lepor H; Wysock J; Taneja SS; Huang WC; Becker DJ; Balar AV; Melamed J; Deng FM; Ren Q; Kufe D; Wong KK; Adeegbe DO; Deng J; Wise DR
    Prostate; 2023 Jun; 83(9):840-849. PubMed ID: 36988342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive profile of TCF1
    Wang D; Fang J; Wen S; Li Q; Wang J; Yang L; Dai W; Lu H; Guo J; Shan Z; Xie W; Liu X; Wen L; Shen J; Wang A; Chen Q; Wang Z
    Int J Oral Sci; 2022 Feb; 14(1):8. PubMed ID: 35153298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Progenitor Exhausted Tissue-Resident Memory CD8
    León-Letelier RA; Castro-Medina DI; Badillo-Godinez O; Tepale-Segura A; Huanosta-Murillo E; Aguilar-Flores C; De León-Rodríguez SG; Mantilla A; Fuentes-Pananá EM; López-Macías C; Bonifaz LC
    Front Immunol; 2020; 11():583382. PubMed ID: 33240271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR6 is required for antitumor efficacy of intratumoral CD8
    Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.
    Bae EA; Seo H; Kim BS; Choi J; Jeon I; Shin KS; Koh CH; Song B; Kim IK; Min BS; Han YD; Shin SJ; Kang CY
    Cancer Res; 2018 Sep; 78(18):5315-5326. PubMed ID: 30012672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ansofaxine hydrochloride inhibits tumor growth and enhances Anti-TNFR2 in murine colon cancer model.
    Jing Q; Wan Q; Nie Y; Luo J; Zhang X; Zhu L; Gui H; Li L; Wang C; Chen S; Wang M; Yuan H; Lv H; Pan R; Jing Q; Nie Y
    Front Pharmacol; 2023; 14():1286061. PubMed ID: 38161697
    [No Abstract]   [Full Text] [Related]  

  • 20. Deletion of Cbl-b inhibits CD8
    Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.